CFO of Seattle Genetics Inc (30-Year Financial, Insider Trades) Todd E Simpson (insider trades) sold 20,000 shares of SGEN on 08/03/2020 at an average price of $165.72 a share. The total sale was $3.3 million.
Seattle Genetics Inc is a biotechnology company. The company is focused on development and commercialization of targeted therapies for the treatment of cancer. Its products are ADCETRIS (brentuximab vedotin) US and ADCETRIS (brentuximab vedotin) Canada. Seattle Genetics Inc has a market cap of $28.29 billion; its shares were traded at around $162.59 with and P/S ratio of 27.47. GuruFocus has detected 1 severe warning sign with Seattle Genetics Inc. .
CEO Recent Trades:
- President and CEO Clay B Siegall sold 28,472 shares of SGEN stock on 07/08/2020 at the average price of $175.08. The price of the stock has decreased by 7.13% since.
CFO Recent Trades:
- CFO Todd E Simpson sold 20,000 shares of SGEN stock on 08/03/2020 at the average price of $165.72. The price of the stock has decreased by 1.89% since.
Directors and Officers Recent Trades:
- Chief Technical Officer Vaughn B Himes sold 8,000 shares of SGEN stock on 07/17/2020 at the average price of $179.42. The price of the stock has decreased by 9.38% since.
For the complete insider trading history of SGEN, click here
.
